Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Launched by KOWA RESEARCH EUROPE · Jun 23, 2006

About Kowa Research Europe

Kowa Research Europe is a leading clinical research organization dedicated to advancing healthcare through innovative clinical trials and patient-centered research. As a subsidiary of Kowa Company, Ltd., a prominent Japanese pharmaceutical firm, Kowa Research Europe focuses on developing novel therapeutic solutions across various therapeutic areas, including cardiovascular, metabolic, and dermatological conditions. The organization emphasizes collaboration with healthcare professionals and regulatory bodies to ensure the highest standards of scientific integrity and patient safety. With a commitment to excellence, Kowa Research Europe strives to contribute significantly to the global advancement of medical science and improve patient outcomes.